Skip to Content
Jump to the top of the page

Showing 1200 – 1210 of 1304 results

  • Moss Quarterly

    Read our quarterly global market review and outlook.

  • Assetmark Quarterly

    Read our quarterly global market review and outlook.

  • Melka Quarterly

    Read our quarterly global market review and outlook.

  • Mersana Therapeutics Inc Initiation

    William Blair initiated research coverage of Mersana Therapeutics, Inc. (MRSN $0.57), whose lead program emiltatug ledadotin is an ADC that targets B7-H4; it is in Phase I development for TNBC. The company is also developing a HER2-targeted immune-stimulating ADC, XMT-2056, in a Phase I solid tumor study.

  • Cardiff Oncology Inc Initiation

    William Blair initiated research coverage of Cardiff Oncology, Inc. (CRDF $6.43), a clinical-stage biotechnology company that leverages deep insights into synthetic lethality through PLK1 inhibition in cancers. The company is advancing three clinical programs in parallel in colorectal, prostate, and pancreatic cancer.

  • Brickell Biotech Inc Initiation

    William Blair initiated research coverage of Brickell Biotech, Inc. (BBI $0.21), a clinical-stage biopharmaceutical company developing therapies to treat autoimmune, inflammatory, and other debilitating diseases.

  • Fusion Pharmaceuticals and Point Biopharma Global Initiation

    William Blair initiated research coverage of Fusion Pharmaceuticals Inc. (FUSN $2.53) and POINT Biopharma Global Inc. (PNT $6.81), two companies in what analyst Andy Hsieh describes as the “reignited” space of radiopharmaceuticals for the treatment of cancer.

  • William Blair Initiates Coverage of Six Companies in the Silicon Carbide Industry

    William Blair initiated research coverage of a group of six companies that directly contribute to the silicon carbide semiconductor industry supply chain.

  • Genmab-AS-and-Janux-Therapeutics

    William Blair initiated research coverage of Genmab A/S (GMAB $43.50) and Janux Therapeutics, Inc. (JANX $16.95).

  • CrowdStrike Holdings and SentinelOne Initiation

    William Blair initiated research coverage of CrowdStrike Holdings, Inc. (CRWD $124.68) and SentinelOne, Inc. (S $16.64), both leading providers of cybersecurity solutions.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures